ProMIS Neurosciences Inc.
PMN Nasdaq
SEC CIK 1374339
Follow ProMIS Neurosciences
Weekly email: filings, results
Net income
−$8.2M
+29.5% vs same quarter last year
EPS, diluted
−$0.89
+85% vs same quarter last year
Operating cash flow
−$9.4M
+6.7% vs same quarter last year
Operating income
−$8.6M
+26.7% vs same quarter last year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY25 | −$39.7M |
| FY24 | $2.8M |
| FY23 | −$13.2M |
| FY22 | −$18.1M |
| FY21 | −$9.8M |
| FY20 | - |